We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $328M
1-Year Est. Return 9.77%
This Fund
S&P 500
This Quarter Est. Return
+9.51%
1 Year Est. Return
+9.77%
3 Year Est. Return
+50.33%
5 Year Est. Return
+74.21%
10 Year Est. Return
+345.05%
AUM
$2.24B
AUM Growth
+$127M
Cap. Flow
-$22.4M
Cap. Flow %
-1%
Top 10 Hldgs %
23.56%
Holding
2,404
New
91
Increased
577
Reduced
648
Closed
51

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$5.38M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$3.16M
3
XOM icon
ExxonMobil
XOM
+$2.1M
4
MSFT icon
Microsoft
MSFT
+$1.73M
5
TWTR
Twitter, Inc.
TWTR
+$1.72M

Sector Composition

Rank Sector Weight
1 Technology 20.14%
2 Healthcare 13.98%
3 Financials 12.55%
4 Consumer Discretionary 8.54%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCGO icon
1676
DocGo
DCGO
$64.5M
$36.3K ﹤0.01%
5,139
FFIC
1677
DELISTED
Flushing Financial
FFIC
$36.1K ﹤0.01%
1,862
ALLO icon
1678
Allogene Therapeutics
ALLO
$683M
$36K ﹤0.01%
5,719
+1,286
+29% +$11.9K
IIIN icon
1679
Insteel Industries
IIIN
$634M
$35.9K ﹤0.01%
1,306
BOC icon
1680
Boston Omaha
BOC
$431M
$35.9K ﹤0.01%
1,354
ATEX icon
1681
Anterix
ATEX
$1.79B
$35.9K ﹤0.01%
1,115
FARO
1682
DELISTED
Faro Technologies
FARO
$35.9K ﹤0.01%
1,219
BFST icon
1683
Business First Bancshares
BFST
$1.05B
$35.8K ﹤0.01%
1,617
+498
+45% +$11.4K
SOVO
1684
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
$35.8K ﹤0.01%
2,489
AUPH icon
1685
Aurinia Pharmaceuticals
AUPH
$2.02B
$35.7K ﹤0.01%
8,264
EBS icon
1686
Emergent Biosolutions
EBS
$230M
$35.7K ﹤0.01%
3,021
ECHO
1687
EchoStar
ECHO
$26.6B
$35.6K ﹤0.01%
2,136
ALEC icon
1688
Alector
ALEC
$228M
$35.6K ﹤0.01%
3,857
BLUE
1689
DELISTED
bluebird bio
BLUE
$35.6K ﹤0.01%
257
+23
+10% +$3.24K
KELYA icon
1690
Kelly Services Class A
KELYA
$566M
$35.4K ﹤0.01%
2,094
+521
+33% +$8.35K
SNBR
1691
DELISTED
Sleep Number
SNBR
$35.3K ﹤0.01%
1,360
ME
1692
DELISTED
23andMe Holding Co
ME
$35.3K ﹤0.01%
818
SLP icon
1693
Simulations Plus
SLP
$370M
$35.3K ﹤0.01%
966
SPNS
1694
DELISTED
Sapiens International
SPNS
$35.2K ﹤0.01%
1,907
OLO
1695
DELISTED
Olo Inc
OLO
$35.2K ﹤0.01%
5,631
USNA icon
1696
Usana Health Sciences
USNA
$252M
$35.1K ﹤0.01%
660
KE
1697
Kimball Electronics
KE
$626M
$35.1K ﹤0.01%
1,554
HCAT icon
1698
Health Catalyst
HCAT
$132M
$34.7K ﹤0.01%
3,263
BY icon
1699
Byline Bancorp
BY
$1.78B
$34.7K ﹤0.01%
1,509
QVCGA
1700
DELISTED
QVC Group Inc Series A
QVCGA
$34.6K ﹤0.01%
425

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 Portfolio in Review

As of Q4 2022, Metropolitan Life Insurance Company (MetLife) held 2,404 positions worth $2.24B, up 6% from $2.11B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2022 filing shows 91 new, 577 increased, 648 reduced and 51 closed positions. Its largest new stake was Vanguard Total Bond Market: 419,639 shares worth $30.1M. The largest sale was Apple, an estimated $5.38M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2022 buy was Vanguard Total Bond Market: 419,639 shares worth $30.1M.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2022, an estimated $22.6M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2022 reduction was Apple, cutting an estimated $5.38M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Twitter, Inc. in Q4 2022, selling an estimated $1.72M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 24% of its $2.24B portfolio in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife) opened 91 new positions and closed 51 in Q4 2022.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6% quarter-over-quarter to $2.24B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2022, filed 15 Feb 2023.